Table 3.
Time-related Patient Characteristics and Survival a
| Characteristics |
Number of
studies (%) a |
Median survival in days
(IQR) b |
|---|---|---|
| Cancer stage c | 362 (100) | |
| Local | 33 (9) | 165 (26-354) |
| Localy advanced | 162 (45) | 148 (90-220) |
| Metastatic | 301 (83) | 132 (70-211) |
| Recurrent | 15 (4) | 144 (94-246) |
| Diease trajectory c | 273 (100) | |
| Active cancer treatment | 160 (59) | 143 (84-261) |
| No further cancer treatment | 157 (58) | 77 (37-175) |
| Diagnosis | 2 (1) | NA |
| Cured | 2 (1) | NA |
| After death | 39 (14) | NA |
| Study setting c | 392 (100) | |
| Inpatient | 207 (53) | 58 (24-148) |
| Outpatient | 137 (35) | 122 (61-209) |
| Home palliative care (non- hospice) |
54 (14) | 75 (59-104) |
| Inpatient hospice | 53 (14) | 28 (16-71) |
| Hospice day care | 5 (1) | NA |
| ECOG Performance status | 157 (100) | |
| 0 | 4 (3) | 311 (311-311) |
| 1 | 38 (24) | 180 (150-245) |
| 2 | 63 (40) | 121 (090-186) |
| 3 | 42 (27) | 58 (24-84) |
| 4 | 10 (6) | 23 (12-47) |
| Time-related categories d | 378 (100) | |
| 7 days or less | 21 (6) | 3 (3-6) |
| >1-4 weeks | 26 (7) | 19 (14-24) |
| >1-3 months | 87 (23) | 61 (46-75) |
| >4-6 months | 114 (30) | 142 (115-165) |
| >6 months | 130 (34) | 266 (222-383) |
Abbreviations: ECOG = Eastern Cooperative Oncology Group, IQR = Interquartile range
a
Among the studies that reported the time-related characteristics
b
Median survival only based on studies that reported actual survival (247 studies)
c
The percentages add up to above 100% because some studies fall under multiple categories
d
Time-related categories were >6 months, >4-6 months, >1-3 months, >1-4 weeks and 7 days or less according to time-related patient characteristics